Response of serum carboxylated and undercarboxylated osteocalcin to alendronate monotherapy and combined therapy with vitamin K2 in postmenopausal women

Journal of Bone and Mineral Metabolism

Volumn 26, Issue 3, 2008, Pages 260-264

  Hirao, Makoto ^a   Hashimoto, Jun ^a   Ando, Wataru ^a   Ono, Takeshi ^a   Yoshikawa, Hideki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Alendronate; Osteocalcin; Postmenopausal woman; Vitamin K2

Indexed keywords

ALENDRONIC ACID; FARNOQUINONE; OSTEOCALCIN;

AGED; ARTICLE; BONE DENSITY; BONE TURNOVER; CARBOXYLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

1-CARBOXYGLUTAMIC ACID; AGED; ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; FEMALE; FEMUR NECK; HUMANS; OSTEOCALCIN; POSTMENOPAUSE; PROSPECTIVE STUDIES; VITAMIN K 2;

EID: 43549085287     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-007-0823-3     Document Type: Article

References (23)

1. Ensrud KE, Black DM, Palermo L, Bauer DC, Barrett-Connor E, Quandt SA, Thompson DE, Karpf DB (1997) Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial. Arch Intern Med 157:2617-2624
2. Tucci JR, Tonino RP, Emkey RD, Peverly CA, Kher U, Santora AC II (1996) Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis. Am J Med 101:488-501
3. Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Kaneda K, Minaguchi H, Inoue T, Tomita A, Nagata Y, Nakashima M, Orimo H (1998) A placebo-controlled, single-blind study to determine the appropriate alendronate dosage in postmenopausal Japanese patients with osteoporosis. The Alendronate Research Group. Endocr J 45:191-201
4. Szulc P, Chapuy MC, Meunier PJ, Delmas PD (1993) Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 91:1769-1774
5. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD (1997) Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 82:719-724
6. Luukinen H, Kakonen SM, Pettersson K, Koski K, Laippala P, Lovgren T, Kivela SL, Vaananen HK (2000) Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res 15:2473-2478
7. Suttie JW (1995) Vitamin K-dependent carboxylase. Annu Rev Biochem 54:459-477
8. Koshihara Y, Hoshi K (1997) Vitamin K2 enhances osteocalcin accumulation in the extracellular matrix of human osteoblasts in vitro. J Bone Miner Res 12:431-438
9. Miki T, Nakatsuka K, Naka H, Kitatani K, Saito S, Masaki H, Tomiyoshi Y, Morii H, Nishizawa Y (2003) Vitamin K (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis. J Bone Miner Metab 21:161-165
10. 2 (menatetrenone) on bone metabolism in postmenopausal women. Endocr J 49:363-370
11. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15:515-521
12. 2 and bisphosphonate in postmenopausal women with osteoporosis. Yonsei Med J 44:751-756
13. Johnell O, Scheele WH, Lu Y, Reginster JY, Need AG, Seeman E (2002) Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 87:985-992
14. Frediani B, Allegri A, Bisogno S, Marcolongo R (1998) Effects of combined treatment with calcitriol plus alendronate on bone mass and bone turnover in postmenopausal osteoporosis. Two years of continuous treatment. Clin Drug Invest 15(3):235-244
15. Greenspan SL, Resnik NM, Parker RA (2003) Combination therapy with hormone replacement and alendronate for prevention of bone loss in elderly women: a randomized controlled trial. JAMA 289:2525-2533
16. Vermeer C (1990) Gamma-carboxyglutamate-containing proteins and the vitamin K-dependent carboxylase. Biochem J 266:625-636
17. Cowin SC, Moss-Salentijin L, Moss KL (1991) Candidates for the mechanosensory system in bone. J Biomed Eng 113:191-197
18. Aarden EM, Burger EH, Nijweide PJ (1994) Function of osteocytes in bone. J Cell Biochem 55:287-299
19. Burger EH, Klein-Nulend J (1999) Mechanotransduction in bone: role of the lacunocanalicular network. FASEB J 13:S101-S112
20. 2 (menatetrenone) on bone resorption may be related to its side chain. Bone (NY) 16:179-184
21. 2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun 220:515-519
22. Knapen MHJ, Hamulyák K, Vermeer C (1989) The effect of vitamin K supplementation on circulating osteocalcin (bone Gla-protein) and urinary calcium excretion. Ann Intern Med 111:1001-1005
23. Knapen MHJ, Jie KSG, Hamulyák K, Vermeer C (1993) Vitamin-K induced changes in markers for osteoblast activity and urinary calcium loss. Calcif Tissue Int 53:81-85